Forest Labs Subpoenaed Over Hypertension Meds
U.S. Attorney Carmen Ortiz’s office sent an April 20 subpoena to the New York-based company with requests to turn over documents involving its Benicar, Benicar HCT and Azor drugs, Forest said in a statement. Forest and Benicar’s originator, Daiichi Sankyo Inc., co-marketed the drug from 2002 through 2008.
“The company intends to cooperate in responding to the subpoena,” Forest said.
To view the full article, register now.